• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections

Opinion
Video

The panelist discusses Rebyota, a treatment approved by the FDA for preventing recurrent Clostridioides difficile infections in adults who have completed antibiotic treatment for recurrent C difficile infections.

Related Videos
Dr Arielle Kauvar
Dr Brian Koffman
1 expert in this video
1 expert in this video
Paula Rodríguez-Otero, MD, PhD
5 Experts are featured in this series.
5 experts are featured in this series.
5 experts in this video
5 experts in this video
Dr Brian Koffman
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.